Zakhar P. Asaulenko
Zakhar P. Asaulenko has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sergey V. Mosenko
City Hospital No. 40, St. Petersburg 197706, Russia
3 shared publications - Yuri A. Krivolapov
I.I. Mechnikov North-Western State Medical University
3 shared publications - Anna Anisenkova
City hospital № 40
2 shared publications - D. V. Baram
Russian Research Institute of Hematology and Transfusiology
2 shared publications - I.N. Spiridonov
St. Petersburg City Hospital No 40
2 shared publications - Svetlana Viacheslavovna Apalko
City Hospital No. 40, St. Petersburg 197706, Russia
2 shared publications
Latest Publications
- 30 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (4) , 65-73
Breast implant-associated anaplastic large cell lymphoma: a case report and literature review
Breast implant-associated anaplastic large cell lymphoma is a mature CD30-positive T-cell lymphoma that develops around the implant as a peri-implant fluid collection confined by a fibrous capsule, and less commonly as a tumor with infiltrative growth. The disease was recognized as a distinct clinico-pathological entity in 2022 in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This work analyzed current understanding of the disease: epidemiological data, etiopathogenetic aspects, and diagnostic algorithms. The article discusses the association of the disease with textured implants, predominantly manufactured by Allergan Biocell (USA). The main pathogenetic mechanisms are reviewed: chronic inflammation, the role of bacterial biofilms, and JAK/STAT signaling pathway activation. Current approaches to diagnosis and staging are described. The necessity of establishing a national registry of BIA-ALCL cases in the Russian Federation and developing domestic clinical guidelines for optimizing patient management is emphasized. A description of a clinical case of BIA-ALCL is presented, one of the few registered cases in the Russian Federation.
- 30 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (4) , 65-73
Breast implant-associated anaplastic large cell lymphoma: a case report and literature review
Breast implant-associated anaplastic large cell lymphoma is a mature CD30-positive T-cell lymphoma that develops around the implant as a peri-implant fluid collection confined by a fibrous capsule, and less commonly as a tumor with infiltrative growth. The disease was recognized as a distinct clinico-pathological entity in 2022 in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This work analyzed current understanding of the disease: epidemiological data, etiopathogenetic aspects, and diagnostic algorithms. The article discusses the association of the disease with textured implants, predominantly manufactured by Allergan Biocell (USA). The main pathogenetic mechanisms are reviewed: chronic inflammation, the role of bacterial biofilms, and JAK/STAT signaling pathway activation. Current approaches to diagnosis and staging are described. The necessity of establishing a national registry of BIA-ALCL cases in the Russian Federation and developing domestic clinical guidelines for optimizing patient management is emphasized. A description of a clinical case of BIA-ALCL is presented, one of the few registered cases in the Russian Federation.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 22-27
Immunohistochemical method of megakaryocytic lineage staining in bone marrow biopsy specimens as an additional pathomorphological differential diagnostic sign of primary myelofibrosis and essential thrombocythemia
Objective. To evaluate and compare morphometric and histotopographic characteristics of megakaryocytic lineage in preparations stained with H&E or antibodies to CD42b in diagnostic trepanobioptates of bone marrow of patients with primary myelofibrosis and essential thrombocythemia with JAK2 or CALR mutation. Analyze the dimensions and quantity of CD42b-positive megakaryocytes in 1 mm2 area of section and assess suitability of these parameters as an additional differential pathomorphological criterion. Material and methods. 108 trephine biopsies of the bone marrow from patients with primary myelofibrosis (N=53) and essential thrombocythemia (N=55) with JAK2 or CALR mutation were selected. Digitized bone marrow slides stained with H&E or antibodies to CD42b (clone EP409) were the object of study. In every sample the average values of perimeter and area of megakaryocytes were analyzed, as well as the average number of megakaryocytes in 1 mm2 area of myeloid tissue section. Logistic regression analysis was used to describe the relationship between CD42b-positive megakaryocyte characteristics and disease (primary myelofibrosis or essential thrombocythemia). Results. Immunohistochemical examination of bone marrow biopsy specimens using antibodies to CD42b in comparison with H&E staining allows to multiply the number of identifiable megakaryocytes in myeloid tissue by 3.5—4 times (p<0.0001). Statistically significant differences in the mean values of the number of megakaryocytes in 1 mm2 of the section area and megakaryocyte perimeter in patients with primary myelofibrosis and essential thrombocythemia have been demonstrated. ROC analysis (AUC=0.84, 95% CI 0.7782—0.9199) justifies the inclusion of the average perimeter size of CD42b-positive megakaryocytes and their number in 1 mm2 of the section area in the differential diagnostic panel as an additional pathomorphological criterion. Conclusion. The revealed statistically significant differences in quantitative and geometric characteristics of megakaryocytes allowed to calculate differential threshold values of characteristics of megakaryocytic lineage of myeloid tissue in diagnostic trepanobioptates of bone marrow from patients with primary myelofibrosis and essential thrombocythemia. Counting the number of CD42b-positive megakaryocytes in one field of view at a magnification of 400 times was proposed as an additional pathomorphological differential-diagnostic sign.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 22-27
Immunohistochemical method of megakaryocytic lineage staining in bone marrow biopsy specimens as an additional pathomorphological differential diagnostic sign of primary myelofibrosis and essential thrombocythemia
Objective. To evaluate and compare morphometric and histotopographic characteristics of megakaryocytic lineage in preparations stained with H&E or antibodies to CD42b in diagnostic trepanobioptates of bone marrow of patients with primary myelofibrosis and essential thrombocythemia with JAK2 or CALR mutation. Analyze the dimensions and quantity of CD42b-positive megakaryocytes in 1 mm2 area of section and assess suitability of these parameters as an additional differential pathomorphological criterion. Material and methods. 108 trephine biopsies of the bone marrow from patients with primary myelofibrosis (N=53) and essential thrombocythemia (N=55) with JAK2 or CALR mutation were selected. Digitized bone marrow slides stained with H&E or antibodies to CD42b (clone EP409) were the object of study. In every sample the average values of perimeter and area of megakaryocytes were analyzed, as well as the average number of megakaryocytes in 1 mm2 area of myeloid tissue section. Logistic regression analysis was used to describe the relationship between CD42b-positive megakaryocyte characteristics and disease (primary myelofibrosis or essential thrombocythemia). Results. Immunohistochemical examination of bone marrow biopsy specimens using antibodies to CD42b in comparison with H&E staining allows to multiply the number of identifiable megakaryocytes in myeloid tissue by 3.5—4 times (p<0.0001). Statistically significant differences in the mean values of the number of megakaryocytes in 1 mm2 of the section area and megakaryocyte perimeter in patients with primary myelofibrosis and essential thrombocythemia have been demonstrated. ROC analysis (AUC=0.84, 95% CI 0.7782—0.9199) justifies the inclusion of the average perimeter size of CD42b-positive megakaryocytes and their number in 1 mm2 of the section area in the differential diagnostic panel as an additional pathomorphological criterion. Conclusion. The revealed statistically significant differences in quantitative and geometric characteristics of megakaryocytes allowed to calculate differential threshold values of characteristics of megakaryocytic lineage of myeloid tissue in diagnostic trepanobioptates of bone marrow from patients with primary myelofibrosis and essential thrombocythemia. Counting the number of CD42b-positive megakaryocytes in one field of view at a magnification of 400 times was proposed as an additional pathomorphological differential-diagnostic sign.
- Open Access
- 27 May 2024
- Published by ECO-Vector LLC in Morphology
- Vol. 161 (3) , 39-52
Morphofunctional characteristics of the vessels of the small circle of blood circulation in those who died from severe and extremely severe forms of new coronavirus infection
BACKGROUND: An important feature of COVID-19 is the development of pronounced hypercoagulation with an increased risk of thrombotic damage to the pulmonary vascular bed, mainly the pulmonary arteries. Thrombosis of the pulmonary blood vessels causes a local violation of hemodynamics with the development of hyperemia, edema, which leads to a decrease in ventilation of the lung tissue area and serves as one of the causes of respiratory failure. AIM: This study aimed to conduct a morphological and morphometric analysis of the vascular bed of lung tissues in deceased with severe and extremely severe forms of new coronavirus infection who were on inpatient treatment in the period 2020–2022. MATERIALS AND METHODS: A pathomorphologic study of 129 autopsy cases with a confirmed diagnosis of a new coronavirus infection COVID-19 was performed. Morphometric analysis and statistical data processing of the pulmonary vascular system in histologic preparations stained with hematoxylin and eosin stain, orcein stain and Martius Scarlet Blue (MSB) stain was performed. The control group consisted of 14 patients who died of cardiovascular disease with bilateral focal confluent pneumonia. RESULTS: It was found that the proportion of thrombosed vessels in the lung tissues of the deceased was 27.6%. In 87.2% of cases, thrombosis develops in small arteries (lumen diameter 30-500 microns) and small veins (lumen diameter 40–500 microns). The vascular-functional indices of Kernogan and Vogenworth were statistically significantly increased in small arteries and small veins of the 4th order (p=0.001), small arteries (p=0.001) and small veins of the 5th order (p=0.014) compared with the control group. CONCLUSIONS: Diffuse involvement of small caliber blood vessels in the pathological process reflects the severity of specific hemocoagulopathic disorders in the lung tissue. Such disorders lead to the development of ventilation-perfusion disorders and entail an increase in right ventricular failure.
- 27 May 2024
- Published by ECO-Vector LLC in Morphology
- Vol. 161 (3) , 39-52
Open AccessMorphofunctional characteristics of the vessels of the small circle of blood circulation in those who died from severe and extremely severe forms of new coronavirus infection
BACKGROUND: An important feature of COVID-19 is the development of pronounced hypercoagulation with an increased risk of thrombotic damage to the pulmonary vascular bed, mainly the pulmonary arteries. Thrombosis of the pulmonary blood vessels causes a local violation of hemodynamics with the development of hyperemia, edema, which leads to a decrease in ventilation of the lung tissue area and serves as one of the causes of respiratory failure. AIM: This study aimed to conduct a morphological and morphometric analysis of the vascular bed of lung tissues in deceased with severe and extremely severe forms of new coronavirus infection who were on inpatient treatment in the period 2020–2022. MATERIALS AND METHODS: A pathomorphologic study of 129 autopsy cases with a confirmed diagnosis of a new coronavirus infection COVID-19 was performed. Morphometric analysis and statistical data processing of the pulmonary vascular system in histologic preparations stained with hematoxylin and eosin stain, orcein stain and Martius Scarlet Blue (MSB) stain was performed. The control group consisted of 14 patients who died of cardiovascular disease with bilateral focal confluent pneumonia. RESULTS: It was found that the proportion of thrombosed vessels in the lung tissues of the deceased was 27.6%. In 87.2% of cases, thrombosis develops in small arteries (lumen diameter 30-500 microns) and small veins (lumen diameter 40–500 microns). The vascular-functional indices of Kernogan and Vogenworth were statistically significantly increased in small arteries and small veins of the 4th order (p=0.001), small arteries (p=0.001) and small veins of the 5th order (p=0.014) compared with the control group. CONCLUSIONS: Diffuse involvement of small caliber blood vessels in the pathological process reflects the severity of specific hemocoagulopathic disorders in the lung tissue. Such disorders lead to the development of ventilation-perfusion disorders and entail an increase in right ventricular failure.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 85 (5) , 36-44
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic Tumors
The article reviews the changes in the structure of classification, diagnostic criteria for myeloid and histiocytic neoplasms in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (2022). Information is presented regarding new nosological forms, renaming and abolition of some previously existing ones. The importance of molecular genetic studies in the isolation of myeloid and histiocytic neoplasms and the need to apply these studies in clinical practice are emphasized. Myeloid and histiocytic precancerous and proliferative processes, genetic tumor syndromes, introduced into the classification for the first time, are considered.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 85 (5) , 36-44
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic Tumors
The article reviews the changes in the structure of classification, diagnostic criteria for myeloid and histiocytic neoplasms in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (2022). Information is presented regarding new nosological forms, renaming and abolition of some previously existing ones. The importance of molecular genetic studies in the isolation of myeloid and histiocytic neoplasms and the need to apply these studies in clinical practice are emphasized. Myeloid and histiocytic precancerous and proliferative processes, genetic tumor syndromes, introduced into the classification for the first time, are considered.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 85 (4) , 24-31
WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors
The paper discusses changes in the structure of the classification, criteria for the diagnosis of lymphoid neoplasms in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (2022). Changes are presented regarding new nosological units, renaming and abolition of some previously existing ones. The importance of molecular genetic studies in the isolation of many lymphomas and the need to apply these studies in everyday clinical practice are emphasized. Lymphoid precancerous processes and lymphoid proliferations introduced into the Classification for the first time are considered.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 85 (4) , 24-31
WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors
The paper discusses changes in the structure of the classification, criteria for the diagnosis of lymphoid neoplasms in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (2022). Changes are presented regarding new nosological units, renaming and abolition of some previously existing ones. The importance of molecular genetic studies in the isolation of many lymphomas and the need to apply these studies in everyday clinical practice are emphasized. Lymphoid precancerous processes and lymphoid proliferations introduced into the Classification for the first time are considered.
- Open Access
- 15 March 2021
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 12 (1) , 5-15
Major predictive risk factors for а cytokine storm in COVID-19 patients (a retrospective clinical trials)
Background: According to WHO, as of March 31, 2021, 127 877 462 confirmed cases of the new COVID-19 coronavirus infection were registered in the world, including 2 796 561 deaths (WHO Coronavirus Disease). COVID-19 is characterized by a wide range of clinical manifestations, from asymptomatic to a rapid progression to severe and extremely severe. Predictive biomarkers for the early detection of high-risk individuals have become a matter of great medical urgency. Aims: Search for the predictors of a cytokine storm in patients with COVID-19 infection and creation of a risk scale of this complication for practical applications. Methods: The study included 458 patients with confirmed COVID-19 infection with signs of viral lung lesions according to the computer tomography data. The patients were divided into 2 groups: those with a stable course of moderate severity (100 patients) and those with progressive moderate, severe and extremely severe course (358 patients). Results: It has been established that the main risk factors for the development of a cytokine storm in COVID-19 patients are the following: interleukin-6 concentration 23 pg/ ml, dynamics of the index on the NEWS scale 0, ferritin concentration 485 ng/ml, D-dimer concentration 2.1, C-reactive protein concentration 50 mg/l, number of lymphocytes in the blood 0.72109/l, age 40 years. The cytokine storm incidence correlates with an increase in the number of risk factors. For the practical testing the scale was applied in 3 groups. In patients of the first group (01 factor) almost no cytokine storm risk was found, in the second group (2 -3 factors) the probability of the storm was 55% (increase by 35.5 times), in the third group (4 risk factors) it reached 96% (increase by 718 times). Conclusion: The diagnostic and monitoring criteria of a cytokine storm have been established in patients with COVID-19 infection. The developed prognostic scale allows identification of patients at high risk of developing a cytokine storm so that early anti-inflammatory therapy could be started.
- 15 March 2021
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 12 (1) , 5-15
Open AccessMajor predictive risk factors for а cytokine storm in COVID-19 patients (a retrospective clinical trials)
Background: According to WHO, as of March 31, 2021, 127 877 462 confirmed cases of the new COVID-19 coronavirus infection were registered in the world, including 2 796 561 deaths (WHO Coronavirus Disease). COVID-19 is characterized by a wide range of clinical manifestations, from asymptomatic to a rapid progression to severe and extremely severe. Predictive biomarkers for the early detection of high-risk individuals have become a matter of great medical urgency. Aims: Search for the predictors of a cytokine storm in patients with COVID-19 infection and creation of a risk scale of this complication for practical applications. Methods: The study included 458 patients with confirmed COVID-19 infection with signs of viral lung lesions according to the computer tomography data. The patients were divided into 2 groups: those with a stable course of moderate severity (100 patients) and those with progressive moderate, severe and extremely severe course (358 patients). Results: It has been established that the main risk factors for the development of a cytokine storm in COVID-19 patients are the following: interleukin-6 concentration 23 pg/ ml, dynamics of the index on the NEWS scale 0, ferritin concentration 485 ng/ml, D-dimer concentration 2.1, C-reactive protein concentration 50 mg/l, number of lymphocytes in the blood 0.72109/l, age 40 years. The cytokine storm incidence correlates with an increase in the number of risk factors. For the practical testing the scale was applied in 3 groups. In patients of the first group (01 factor) almost no cytokine storm risk was found, in the second group (2 -3 factors) the probability of the storm was 55% (increase by 35.5 times), in the third group (4 risk factors) it reached 96% (increase by 718 times). Conclusion: The diagnostic and monitoring criteria of a cytokine storm have been established in patients with COVID-19 infection. The developed prognostic scale allows identification of patients at high risk of developing a cytokine storm so that early anti-inflammatory therapy could be started.
- 1 January 2021
- Published by PREVENTIVE AND CLINICAL MEDICINE, North-Western State Medical University named after I.I. Mechnikov in Профилактическая и клиническая медицина
- No. 4,p. 90-99
THE EXPERIENCE OF CLINICAL AND MORPHOLOGICAL ANALYSIS OF FATAL CASES OF CORONAVIRUS INFECTION OF THE "FIRST WAVE" (SPRING-AUTUMN 2020)
Введение. Изучение патоморфогенеза и танатогенеза при новой коронавирусной инфекции стало в период 2020-2021 гг. новым профессиональным вызовом для патологоанатомической службы и во многом определило основное направление диагностической и научно-исследовательской деятельности в этот период.Цель: провести клинико-морфологических анализ летальных исходов и обобщить полученный опыт исследования тел пациентов, находившихся на стационарном лечении в первую волну пандемии и умерших от тяжелых форм новой коронавирусной инфекции.Материалы и методы. В исследование включены клинико-морфологические данные, полученные при изучении медицинской документации и тел 101 пациента с прижизненно и (или) посмертно подтвержденной новой коронавирусной инфекцией.Результаты и обсуждение. Установлено, что наибольшая доля умерших относится к группам пожилого (60-74 года) и старческого (75-90 лет) возрастов - 38% и 43% соответственно; умерших молодого возраста - 2 (34-44).При госпитализации у половины выявлялось поражение легких тяжелых степеней: КТ-3 и КТ-4 - в 31,1% и 28,5% соответственно, в остальных случаях поражение легкого прогрессировало уже в больнице. В работе приведены данные о средних сроках госпитализации, коморбидности, усредненные показатели клинического и биохимического анализов крови, результаты вскрытий. Установлено, что основным типом терминального состояния был легочный (79%), связанный с развитием острого респираторного дистресс-синдрома и нарастанием дыхательной недостаточности; у 19% умерших выявлен сердечный механизм смерти; в 2% случаев причиной смерти явилась общая интоксикация. Патогистологически в легких у умерших выявлены признаки различных фаз диффузного альвеолярного повреждения, а у пациентов, длительно находившихся на стационарном лечении, обнаруживали нарастающий фиброз легкого и патологическую регенерацию бронхиального и респираторного эпителиев. Продемонстрирован результат иммуно-гистохимического выявления N- и S-протеины вируса SARS-CoV-2 в клетках легкого.Заключение. В проведенном исследовании выявлены клинико-морфологические связи у пациентов с тяжелыми формами коронавирусной инфекции, установлен танатологический профиль при неблагоприятном течении...
- 1 January 2021
- Published by PREVENTIVE AND CLINICAL MEDICINE, North-Western State Medical University named after I.I. Mechnikov in Профилактическая и клиническая медицина
- No. 4,p. 90-99
THE EXPERIENCE OF CLINICAL AND MORPHOLOGICAL ANALYSIS OF FATAL CASES OF CORONAVIRUS INFECTION OF THE "FIRST WAVE" (SPRING-AUTUMN 2020)
Введение. Изучение патоморфогенеза и танатогенеза при новой коронавирусной инфекции стало в период 2020-2021 гг. новым профессиональным вызовом для патологоанатомической службы и во многом определило основное направление диагностической и научно-исследовательской деятельности в этот период.Цель: провести клинико-морфологических анализ летальных исходов и обобщить полученный опыт исследования тел пациентов, находившихся на стационарном лечении в первую волну пандемии и умерших от тяжелых форм новой коронавирусной инфекции.Материалы и методы. В исследование включены клинико-морфологические данные, полученные при изучении медицинской документации и тел 101 пациента с прижизненно и (или) посмертно подтвержденной новой коронавирусной инфекцией.Результаты и обсуждение. Установлено, что наибольшая доля умерших относится к группам пожилого (60-74 года) и старческого (75-90 лет) возрастов - 38% и 43% соответственно; умерших молодого возраста - 2 (34-44).При госпитализации у половины выявлялось поражение легких тяжелых степеней: КТ-3 и КТ-4 - в 31,1% и 28,5% соответственно, в остальных случаях поражение легкого прогрессировало уже в больнице. В работе приведены данные о средних сроках госпитализации, коморбидности, усредненные показатели клинического и биохимического анализов крови, результаты вскрытий. Установлено, что основным типом терминального состояния был легочный (79%), связанный с развитием острого респираторного дистресс-синдрома и нарастанием дыхательной недостаточности; у 19% умерших выявлен сердечный механизм смерти; в 2% случаев причиной смерти явилась общая интоксикация. Патогистологически в легких у умерших выявлены признаки различных фаз диффузного альвеолярного повреждения, а у пациентов, длительно находившихся на стационарном лечении, обнаруживали нарастающий фиброз легкого и патологическую регенерацию бронхиального и респираторного эпителиев. Продемонстрирован результат иммуно-гистохимического выявления N- и S-протеины вируса SARS-CoV-2 в клетках легкого.Заключение. В проведенном исследовании выявлены клинико-морфологические связи у пациентов с тяжелыми формами коронавирусной инфекции, установлен танатологический профиль при неблагоприятном течении...